Glynn Morrish

441 total citations
12 papers, 351 citations indexed

About

Glynn Morrish is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Glynn Morrish has authored 12 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Surgery. Recurrent topics in Glynn Morrish's work include Radiopharmaceutical Chemistry and Applications (3 papers), Prostate Cancer Treatment and Research (3 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Glynn Morrish is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Prostate Cancer Treatment and Research (3 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Glynn Morrish collaborates with scholars based in Australia, United States and Netherlands. Glynn Morrish's co-authors include Bruce Green, Carl M. J. Kirkpatrick, Sarah McLeay, Manjunath P. Pai, Paul Handley, Keith Dredge, Edward Hammond, Michael Millward, Liwen Lin and Michael P. Brown and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Pharmaceutical Research.

In The Last Decade

Glynn Morrish

11 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Glynn Morrish Australia	6	73	72	59	53	51	12	351
PE Rolan United Kingdom	6	75 1.0×	57 0.8×	18 0.3×	50 0.9×	34 0.7×	7	382
Patrick Mayo Canada	12	91 1.2×	48 0.7×	14 0.2×	79 1.5×	46 0.9×	26	441
Hyewon Chung South Korea	16	128 1.8×	50 0.7×	13 0.2×	57 1.1×	69 1.4×	45	592
F Hartmann Germany	13	105 1.4×	32 0.4×	21 0.4×	35 0.7×	44 0.9×	48	434
Shaun S. Kumar United States	11	122 1.7×	65 0.9×	10 0.2×	91 1.7×	52 1.0×	23	394
Valerian C. Dias Canada	15	116 1.6×	56 0.8×	20 0.3×	25 0.5×	240 4.7×	36	586
Manuel Tufoni Italy	12	80 1.1×	47 0.7×	28 0.5×	17 0.3×	109 2.1×	26	554
Anil Pareek India	12	45 0.6×	115 1.6×	14 0.2×	16 0.3×	49 1.0×	29	443
A. Quintanilla United States	11	115 1.6×	50 0.7×	20 0.3×	76 1.4×	52 1.0×	46	494
F J Frey Switzerland	14	79 1.1×	62 0.9×	11 0.2×	62 1.2×	60 1.2×	28	589

Countries citing papers authored by Glynn Morrish

Since Specialization

Citations

This map shows the geographic impact of Glynn Morrish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glynn Morrish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glynn Morrish more than expected).

Fields of papers citing papers by Glynn Morrish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glynn Morrish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glynn Morrish. The network helps show where Glynn Morrish may publish in the future.

Co-authorship network of co-authors of Glynn Morrish

This figure shows the co-authorship network connecting the top 25 collaborators of Glynn Morrish. A scholar is included among the top collaborators of Glynn Morrish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glynn Morrish. Glynn Morrish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Nordquist, Luke T., David Josephson, Gregg E. Franklin, et al.. (2025). COBRA: Assessment of the efficacy of ⁶⁴ Cu-SAR-bisPSMA using histopathology and standard of care imaging as reference standard in patients with biochemical recurrence of prostate cancer following definitive therapy.. Journal of Clinical Oncology. 43(16_suppl). 5102–5102.

Nordquist, Luke T., Daniel R. Saltzstein, David Josephson, et al.. (2024). COBRA: Assessment of safety and efficacy of ⁶⁴Cu-SAR-bisPSMA in patients with biochemical recurrence of prostate cancer following definitive therapy.. Journal of Clinical Oncology. 42(16_suppl). 5100–5100. 1 indexed citations

Gorin, Michael A., Luke T. Nordquist, Glynn Morrish, et al.. (2024). CLARIFY: Positron emission tomography using ⁶⁴Cu-SAR-bisPSMA in patients with high-risk prostate cancer prior to radical prostatectomy (a phase 3 diagnostic study).. Journal of Clinical Oncology. 42(16_suppl). TPS5129–TPS5129. 1 indexed citations

Dredge, Keith, Todd V. Brennan, Edward Hammond, et al.. (2018). A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours. British Journal of Cancer. 118(8). 1035–1041. 73 indexed citations

McLeay, Sarah, et al.. (2014). Noninvasive Quantification of Hepatic Steatosis: Relationship BetweenObesity Status and Liver Fat Content. 6(1). 16–24. 4 indexed citations

Perri, Giovanni Di, Bruce Green, Glynn Morrish, et al.. (2013). Pharmacokinetics and Pharmacodynamics of Etravirine 400 mg Once Daily in Treatment-Naïve Patients. HIV Clinical Trials. 14(3). 92–98. 5 indexed citations

McLeay, Sarah, Glynn Morrish, Carl M. J. Kirkpatrick, & Bruce Green. (2012). The Relationship between Drug Clearance and Body Size. Clinical Pharmacokinetics. 51(5). 319–330. 134 indexed citations

Hasselt, J. G. Coen van, Bruce Green, & Glynn Morrish. (2012). Leveraging Physiological Data from Literature into a Pharmacokinetic Model to Support Informative Clinical Study Design in Pregnant Women. Pharmaceutical Research. 29(6). 1609–1617. 9 indexed citations

Morrish, Glynn, Manjunath P. Pai, & Bruce Green. (2011). The effects of obesity on drug pharmacokinetics in humans. Expert Opinion on Drug Metabolism & Toxicology. 7(6). 697–706. 80 indexed citations

10.

McLeay, Sarah, Glynn Morrish, Carl M. J. Kirkpatrick, & Bruce Green. (2009). Encouraging the Move Towards Predictive Population Models for the Obese Using Propofol as a Motivating Example. Pharmaceutical Research. 26(7). 1626–1634. 28 indexed citations

11.

McLeay, Sarah, et al.. (2007). Lean bodyweight as a descriptor for propofol clearance. Queensland's institutional digital repository (The University of Queensland). 147–147. 1 indexed citations

12.

Morrish, Glynn, David Foster, & Andrew A. Somogyi. (2005). Differentialin vitroinhibition of M3G and M6G formation from morphine by (R)‐ and (S)‐methadone and structurally related opioids. British Journal of Clinical Pharmacology. 61(3). 326–335. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact